Works matching DE "EXTRANODAL NK-T-cell lymphoma"

Results: 116
    1
    2

    Forecasting optimal treatments in relapsed/refractory mature T‐ and NK‐cell lymphomas: A global PETAL Consortium study.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1664, doi. 10.1111/bjh.20063
    By:
    • Sorial, Mark N.;
    • Han, Jessy Xinyi;
    • Koh, Min Jung;
    • Boussi, Leora;
    • Li, Sijia;
    • Duan, Rui;
    • Lu, Junwei;
    • Lei, Matthew M.;
    • MacVicar, Caroline T.;
    • Freydman, Jessica;
    • Malespini, Jack;
    • Aniagboso, Kenechukwu N.;
    • McCabe, Sean M.;
    • Peng, Luke;
    • Singh, Shambhavi;
    • Iwasaki, Makoto;
    • Eche‐Ugwu, Ijeoma Julie;
    • Gabler, Judith;
    • Fernandez Turizo, Maria J.;
    • Garg, Aditya
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.

    Published in:
    PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261469
    By:
    • de Mel, Sanjay;
    • Mustafa, Nurulhuda;
    • Selvarajan, Viknesvaran;
    • Azaman, Muhammad Irfan;
    • Jaynes, Patrick William;
    • Venguidessane, Shruthi;
    • Phuong, Hoang Mai;
    • Alnaseri, Zubaida Talal;
    • Phyu, The;
    • Girard, Louis-Pierre;
    • Chng, Wee Joo;
    • Wardyn, Joanna;
    • Li, Ying;
    • An, Omer;
    • Yang, Henry;
    • Ng, Siok Bian;
    • Jeyasekharan, Anand D.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Risk‐dependent curability of radiotherapy for elderly patients with early‐stage extranodal nasal‐type NK/T‐cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).

    Published in:
    Cancer Medicine, 2018, v. 7, n. 12, p. 5952, doi. 10.1002/cam4.1849
    By:
    • Chen, Bo;
    • Zhu, Su‐Yu;
    • Shi, Mei;
    • Su, Hang;
    • Wang, Ying;
    • He, Xia;
    • Xu, Li‐Ming;
    • Yuan, Zhi‐Yong;
    • Zhang, Li‐Ling;
    • Wu, Gang;
    • Qu, Bao‐Lin;
    • Qian, Li‐Ting;
    • Hou, Xiao‐Rong;
    • Zhang, Fu‐Quan;
    • Zhang, Yu‐Jing;
    • Zhu, Yuan;
    • Cao, Jian‐Zhong;
    • Lan, Sheng‐Min;
    • Wu, Jun‐Xin;
    • Wu, Tao
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL).

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 12, p. 1914, doi. 10.1080/10428194.2023.2244101
    By:
    • Rajendra, Akhil;
    • Sengar, Manju;
    • Bonda, V.N. Avinash;
    • Jain, Hasmukh;
    • Nayak, Lingaraj;
    • Thorat, Jayashree;
    • Shet, Tanuja;
    • Epari, Sridhar;
    • Laskar, Siddharth;
    • Aggarwal, Archi;
    • Rangarajan, V.;
    • Gujral, Sumeet;
    • Bagal, Bhausaheb;
    • Kakoti, Sangeeta;
    • Salvi, Omkar
    Publication type:
    Article
    32

    Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2679, doi. 10.1080/10428194.2019.1599111
    By:
    • Qi, Fei;
    • Chen, Bo;
    • Wang, Jingjing;
    • Lin, Xinyi;
    • Qi, Shunan;
    • Yang, Jianliang;
    • Zhou, Shengyu;
    • Wang, Shulian;
    • Gui, Lin;
    • Fang, Hui;
    • Liu, Peng;
    • Song, Yongwen;
    • Yang, Sheng;
    • Li, Yexiong;
    • Dong, Mei
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50